Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New treatment approaches target tumors with shared characteristics, regardless of where they appear in the body.
Imfinzi tripled progression-free survival in previously treated patients with inoperable lung cancer.
Cancer and HIV are invaders that the immune system fails to detect, and the similarities don’t end there.
Individually designed vaccines help T cells recognize specific markers on tumor cells
Trials of immunotherapy drug for multiple myeloma suspended after patient deaths.
Keytruda shows promise in treating an aggressive form of the cancer that occurs more often in younger women, especially young Black women.
Findings from three clinical trials of larotrectinib were presented at this year’s American Society of Clinical Oncology in Chicago.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.